Tanimoto Sarina sold SPRY

February 26, 2024 · Form 4 insider transaction

Tanimoto Sarina sold 100 shares of ARS Pharmaceuticals, Inc. at $9.01 per share, a transaction worth $901.00. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
100
Price
$9.01
Total value
$901.00
RoleOfficer, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2024
Filing dateFebruary 28, 2024
Shares owned after1,772,750
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.; The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR
Tanimoto Sarina sold SPRY: February 26, 2024 | Insider Trading Screener